✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Hycodan is a drug marketed by Genus and is included in one NDA.
The generic ingredient in HYCODAN is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
A generic version of HYCODAN was approved as homatropine methylbromide; hydrocodone bitartrate by NOVEL LABS INC on April 20th, 2011.
Anatomical Therapeutic Chemical (ATC) Classes for HYCODAN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Genus||HYCODAN||homatropine methylbromide; hydrocodone bitartrate||SYRUP;ORAL||005213-002||Jul 26, 1988||AA||RX||Yes||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Genus||HYCODAN||homatropine methylbromide; hydrocodone bitartrate||TABLET;ORAL||005213-001||Jul 26, 1988||AA||RX||Yes||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|